0001415889-18-000693.txt : 20180508 0001415889-18-000693.hdr.sgml : 20180508 20180508162142 ACCESSION NUMBER: 0001415889-18-000693 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180102 FILED AS OF DATE: 20180508 DATE AS OF CHANGE: 20180508 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FORTUNOFF GREGORY CENTRAL INDEX KEY: 0001212542 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-00935 FILM NUMBER: 18814915 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Medite Cancer Diagnostics, Inc. CENTRAL INDEX KEY: 0000075439 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 364296006 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 414 NORTH ORLEANS STREET STREET 2: SUITE 502 CITY: CHICAGO STATE: IL ZIP: 60610 BUSINESS PHONE: 4078490290 MAIL ADDRESS: STREET 1: 414 NORTH ORLEANS STREET STREET 2: SUITE 502 CITY: CHICAGO STATE: IL ZIP: 60610 FORMER COMPANY: FORMER CONFORMED NAME: CytoCore Inc DATE OF NAME CHANGE: 20060815 FORMER COMPANY: FORMER CONFORMED NAME: MOLECULAR DIAGNOSTICS INC DATE OF NAME CHANGE: 20011009 FORMER COMPANY: FORMER CONFORMED NAME: AMPERSAND MEDICAL CORP DATE OF NAME CHANGE: 19990527 3 1 form3-05082018_010528.xml X0206 3 2018-01-02 0 0000075439 Medite Cancer Diagnostics, Inc. MDIT 0001212542 FORTUNOFF GREGORY C/O MEDITE CANCER DIAGNOSTICS, INC. 4203 SW 34TH ST. ORLANDO FL 32811 true false false false Common Stock 200000 D Warrant 0.50 2017-03-28 2022-03-28 Common Stock 50000 D Warrant 0.50 2017-05-17 2022-05-17 Common Stock 50000 D Secured Convertible Note 0.65 2017-09-27 2020-09-27 Common Stock 300000 D Warrant 0.60 2017-09-27 2022-03-26 Common Stock 236687 D Secured Convertible Note 0.65 2017-12-21 2020-12-21 Common Stock 200000 D Warrant 0.60 2017-12-21 2022-12-21 Common Stock 157791 D /s/ Greg Fortunoff 2018-05-08